Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Saved in:

Bibliographic Details
Published in	Diabetologia Vol. 55; no. 6; pp. 1577 - 1596
Main Authors	Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., Matthews, D. R.
Format	Journal Article
Language	English
Published	Berlin/Heidelberg Springer-Verlag 01.06.2012 Springer Nature B.V
Subjects	Decision making Diabetes Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - drug therapy Diabetes Mellitus, Type 2 - epidemiology Diabetes Mellitus, Type 2 - pathology Disease Management Endocrinology Europe Human Physiology Humans Hyperglycemia Hyperglycemia - drug therapy Hyperglycemia - epidemiology Hyperglycemia - etiology Hyperglycemia - pathology Hypoglycemic Agents - therapeutic use Internal Medicine Medicine Medicine & Public Health Metabolic Diseases Patient-centered care Peptides Position Statement Societies, Medical United States Writing United States Europe United Kingdom > UK United States > US Gliclazide Glycaemic Control Metformin Beta Cell Dysfunction Optimal Therapeutic Strategy
Online Access	Get full text
ISSN	0012-186X 1432-0428 1432-0428
DOI	10.1007/s00125-012-2534-0

More Information
Bibliography:	ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23
ISSN:	0012-186X 1432-0428 1432-0428
DOI:	10.1007/s00125-012-2534-0